Vertex Pharmaceuticals won approval from the U.S. Food and Drug Administration for a non-opioid pain drug, clearing the way ...

RFK Jr.'s comments about the gene-editing technology raise a question about how he would regulate it as head of HHS.

The FDA has lost no time in approving Vertex Pharma and CRISPR Therapeutics pioneering gene-editing therapy Casgevy for its second use, approving the drug for transfusion-dependent beta ...

that it says build the case for the drug as a phase 3 trial gets underway – but its shares fell sharply as investors reacted to the news. The CRISPR specialist said that a single 50mg infusion ...

Complementary discoveries have the potential to enhance treatment options for antibiotic-resistant infections. Researchers at ...

By creating gene editors not found in nature, or optimizing existing editors, AI can improve the accuracy, effectiveness, and accessibility of gene editing.

Shares of CRISPR Therapeutics CRSP have lost more than ... Another reason behind the dip is the poor performance of the overall drug and biotech sector in the past couple of months after Trump ...

Stanford researchers introduced affordable gene-editing kits ready for the classroom, aiming to make the field more accessible for high school students.

People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...

The U.S. Food and Drug Administration (FDA has cleared the investigational new drug (IND) application for Allogene ...